PLURPluri Inc.

Nasdaq pluri-biotech.com


$ 5.60 $ 0.23 (4.28 %)    

Thursday, 02-May-2024 10:26:39 EDT
QQQ $ 423.79 $ -1.49 (-0.35 %)
DIA $ 380.39 $ -1.21 (-0.32 %)
SPY $ 502.20 $ -2.20 (-0.44 %)
TLT $ 88.62 $ 0.40 (0.45 %)
GLD $ 213.28 $ 0.82 (0.39 %)
$ 5.37
$ 5.55
$ 0.00 x 0
$ 0.00 x 0
$ 5.55 - $ 5.60
$ 3.45 - $ 8.56
21,388
na
27.84M
$ 1.41
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-12-2024 12-31-2023 10-Q
2 11-13-2023 09-30-2023 10-Q
3 09-12-2023 06-30-2023 10-K
4 05-09-2023 03-31-2023 10-Q
5 02-13-2023 12-31-2022 10-Q
6 11-10-2022 09-30-2022 10-Q
7 09-21-2022 06-30-2022 10-K
8 05-09-2022 03-31-2022 10-Q
9 02-07-2022 12-31-2021 10-Q
10 11-08-2021 09-30-2021 10-Q
11 09-13-2021 06-30-2021 10-K
12 05-06-2021 03-31-2021 10-Q
13 02-08-2021 12-31-2020 10-Q
14 11-05-2020 09-30-2020 10-Q
15 09-10-2020 06-30-2020 10-K
16 05-11-2020 03-31-2020 10-Q
17 02-06-2020 12-31-2019 10-Q
18 11-07-2019 09-30-2019 10-Q
19 09-12-2019 06-30-2019 10-K
20 05-06-2019 03-31-2019 10-Q
21 02-06-2019 12-31-2018 10-Q
22 11-07-2018 09-30-2018 10-Q
23 09-12-2018 06-30-2018 10-K
24 05-09-2018 03-31-2018 10-Q
25 02-06-2018 12-31-2017 10-Q
26 11-07-2017 09-30-2017 10-Q
27 09-07-2017 06-30-2017 10-K
28 05-08-2017 03-31-2017 10-Q
29 02-08-2017 12-31-2016 10-Q
30 11-07-2016 09-30-2016 10-Q
31 09-07-2016 06-30-2016 10-K
32 05-09-2016 03-31-2016 10-Q
33 02-08-2016 12-31-2015 10-Q
34 11-05-2015 09-30-2015 10-Q
35 09-09-2015 06-30-2015 10-K
36 05-06-2015 03-31-2015 10-Q
37 02-05-2015 12-31-2014 10-Q
38 11-06-2014 09-30-2014 10-Q
39 09-11-2014 06-30-2014 10-K
40 05-08-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 pluri-introduces-groundbreaking-immune-cell-expansion-technology-secures-new-us-patent

Leading biotechnology company, Pluri Inc. (NASDAQ:PLUR) (TASE:PLUR) ("Pluri" or the "Company"), which transform...

 pluri-receives-patent-approval-for-3d-bioreactor-technology-in-plant-cell-cultivation

The patent titled "A System for 3D Cultivation of Plant Cells and Methods of Use" represents a major breakthrough in Pl...

 pluri-unveils-sustainable-cell-based-coffee-to-tackle-global-coffee-crisis

Pluri to leverage its proprietary 3D technology platform to develop cell-based products for the coffee industry under its new...

 stocks-that-hit-52-week-lows-on-monday

  During Monday, 102 stocks hit new 52-week lows.

 pluri-gets-42m-contract-to-advance-development-of-treatment-for-radiation-syndrome

Pluri Inc. (NASDAQ: PLUR) has signed a three-year, $4.2 million contract with the U.S.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION